Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Urinary Bladder Neoplasms × Immune Checkpoint Inhibitors × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 5 Squamous Cell Carcinoma of Head and Neck 2 Solid Cancers 2 Neoplasms 2 Melanoma 2 Breast Neoplasms 2 Triple Negative Breast Neoplasms 1 Solid Tumors 1 Small Cell Lung Carcinoma 1 Sarcopenia 1 SCLC 1 Rectal Neoplasms 1 Pathologic Complete Response 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Oropharyngeal Neoplasms 1 Neoplasm Metastasis 1 Nasopharyngeal Carcinoma 1 Mouth Neoplasms 1 Immune-Related Adverse Events 1 Glioma 1 Diffuse Intrinsic Pontine Glioma 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Hepatocellular 1 Biliary Tract Neoplasms 1

Interventions

Gemcitabine 15 Specimen Handling 13 Magnetic Resonance Spectroscopy 12 pembrolizumab 11 Cisplatin 10 durvalumab 7 Nivolumab 6 Cystoscopy 6 Docetaxel 5 avelumab 4 atezolizumab 4 Transurethral Resection of Bladder 4 Radiotherapy 4 Radiation 4 Paclitaxel 4 Mitomycin 4 Carboplatin 4 Biopsy 4 erdafitinib 3 enfortumab vedotin 3 cabozantinib 3 Standard of Care 3 Ipilimumab 3 Immunoglobulin G 3 Fluorouracil 3 Disulfides 3 CTLA-4 Antigen 3 sacituzumab govitecan 2 eribulin 2 dehydroftorafur 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡